Why vitamin E therapy fails for treatment of Alzheimer's disease
- PMID: 20061623
- PMCID: PMC3023173
- DOI: 10.3233/JAD-2010-1238
Why vitamin E therapy fails for treatment of Alzheimer's disease
Comment on
-
Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental.J Alzheimers Dis. 2009;17(1):143-9. doi: 10.3233/JAD-2009-1033. J Alzheimers Dis. 2009. PMID: 19494439 Clinical Trial.
References
-
- Sultana R, Boyd-Kimball D, Poon HF, Cai J, Pierce WM, Klein JB, Merchant M, Markesbery WR, Butterfield DA. Redox proteomics identification of oxidized proteins in Alzheimer’s disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. Neurobiol Aging. 2006;27:1564–1576. - PubMed
-
- Markesbery WR, Lovell MA. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer’s disease. Neurobiol Aging. 1998;19:33–36. - PubMed
-
- Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297:842–857. - PubMed
-
- Miller ER, III, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:37–46. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources